Global Cord Blood Corp Receivables Turnover Ratio (CO), from the fourth quarter 2022 to the fourth quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Global Cord Blood Corp  (NYSE: CO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Global Cord Blood Accounts Receivables Turnover Ratio from the fourth quarter 2022 to the fourth quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Global Cord Blood Corp's ability to collect accounts receivable sequentially worsen to 5.78, pointing to a challenging and on top of that deteriorating business climate for the Healthcare Facilities industry. Global Cord Blood's Accounts Receivable average collection period in the Mar 31 2022 quarter, has increased to 63 days, from 57 days, in the 0 quarter.

If we take a look into Healthcare sector 132 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 1306.

What is Receivable Turnover Ratio?
What is Global Cord Blood Corp Selling?


What is Receivable Turnover Ratio?





CO Receivables Turnover Ratio (Mar 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Mar 31 2021)
IV. Quarter
Y / Y Receivable Change 49.38 % 35.07 % 25.23 % 35.07 % 38.26 %
Y / Y Revenue Change 10.8 % - - - 2.6 %
Receivable Turnover Ratio (TTM) 5.78 6.36 8.49 8.87 9.35
CO's Total Ranking # 1306 # 1306 # 0 # 1307 # 0
Accounts Receivable average collection period days 63 57 43 41 39
Seq. Receivable Change 269.04 % -11.42 % 12.9 % -59.52 % 233.69 %
Seq. Revenue Change - - - - 265.08 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 13
Healthcare Sector # 133
Overall Market # 1306

Receivable Turnover Ratio Statistics
High Average Low
11.72 8.77 5.28
(Mar 31 2020)   (Mar 31 2016)






Financial Statements
Global Cord Blood's Accounts Receivable $ 73 Millions Visit CO's Balance sheet
Global Cord Blood's Sales TTM $ 196 Millions Visit CO's Income Statement
Sources of CO's Revenues Visit CO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CO's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CO's Growth Rates CO's Roa CO's Inventory Turnover Ratio CO's Dividend Comparisons
CO's Profitability Ratios CO's Roi CO's Asset Turnover Ratio CO's Dividend Growth
CO's Valuation Ratios CO's Roe CO's Financial Strength Ratios CO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2022 Receivable at quarter ending Mar 31 2022
Lakeland Industries Inc   7.34 $ 111.572  Millions$ 15.191  Millions
Fusion Pharmaceuticals Inc   7.34 $ 2.025  Millions$ 0.276  Millions
Fuse Medical Inc   7.33 $ 20.528  Millions$ 2.801  Millions
Universal Health Services Inc   7.33 $ 12,922.086  Millions$ 1,763.414  Millions
Hca Healthcare Inc   7.31 $ 59,720.000  Millions$ 8,171.000  Millions
3m Company  7.29 $ 35,333.000  Millions$ 4,845.500  Millions
Envista Holdings Corporation  7.27 $ 2,431.100  Millions$ 334.225  Millions
Clearpoint Neuro Inc   7.25 $ 17.300  Millions$ 2.387  Millions
Kiniksa Pharmaceuticals International Plc  7.22 $ 70.733  Millions$ 9.800  Millions
Alphatec Holdings Inc   7.21 $ 270.024  Millions$ 37.438  Millions
Skinhealth Systems Inc   7.21 $ 335.416  Millions$ 46.527  Millions
Merit Medical Systems Inc  7.19 $ 1,101.253  Millions$ 153.096  Millions
Vivos Therapeutics Inc   7.19 $ 17.081  Millions$ 2.375  Millions
Si bone inc   7.17 $ 92.149  Millions$ 12.860  Millions
Myriad Genetics Inc   7.16 $ 682.400  Millions$ 95.350  Millions
Axonics Inc   7.15 $ 194.337  Millions$ 27.189  Millions
Iridex Corp  7.14 $ 54.921  Millions$ 7.693  Millions
Vertex Pharmaceuticals Inc  7.13 $ 7,947.595  Millions$ 1,114.779  Millions
Veru Inc   7.11 $ 60.466  Millions$ 8.509  Millions
Star Equity Holdings Inc   7.08 $ 109.254  Millions$ 15.432  Millions
Cue Health Inc   7.08 $ 733.060  Millions$ 103.577  Millions
Haemonetics Corporation  7.07 $ 992.502  Millions$ 140.286  Millions
Puma Biotechnology Inc   7.05 $ 200.722  Millions$ 28.478  Millions
Quotient Limited  7.04 $ 38.514  Millions$ 5.467  Millions
Tenet Healthcare Corp  7.03 $ 19,449.000  Millions$ 2,767.750  Millions
Teleflex Incorporated  7.02 $ 2,817.353  Millions$ 401.167  Millions
Labcorp Holdings Inc   7.01 $ 15,859.000  Millions$ 2,261.650  Millions
Musclepharm Corporation  7.01 $ 50.022  Millions$ 7.140  Millions
Quidelortho Corp  7.00 $ 2,325.472  Millions$ 332.391  Millions
Neuronetics Inc   7.00 $ 57.205  Millions$ 8.177  Millions

Date modified: 2026-09-18T16:03:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.